Cash Flow Statement
Growth Metrics

Mimedx (MDXG) EPS (Basic) Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,207.14%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -240.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -240.00%
Dec 31, 2025 100.00%
Sep 30, 2025 120.00%
Jun 30, 2025 -41.67%
Mar 31, 2025 -16.67%
Dec 31, 2024 -87.18%
Sep 30, 2024 -16.67%
Jun 30, 2024 71.43%
Mar 31, 2024 300.00%
Dec 31, 2023 2,050.00%
Sep 30, 2023 166.67%
Jun 30, 2023 163.64%
Mar 31, 2023 72.73%
Dec 31, 2022 -57.87%
Sep 30, 2022 -125.00%
Jun 30, 2022 -266.67%
Mar 31, 2022 -22.22%
Dec 31, 2021 92.55%
Sep 30, 2021 91.67%
Jun 30, 2021 62.50%
Mar 31, 2021 -125.00%
Dec 31, 2020 -142.86%
Sep 30, 2020 -500.00%
Jun 30, 2020 50.00%
Mar 31, 2020 66.67%
Dec 31, 2019 79.41%
Sep 30, 2019 7,241.74%
Jun 30, 2019 -900.00%
Mar 31, 2019 -400.00%
Dec 31, 2018 -950.00%
Sep 30, 2018 -100.41%
Jun 30, 2018 -80.00%
Mar 31, 2018 -33.33%
Dec 31, 2017 -20.00%
Sep 30, 2017 1,266.67%
Jun 30, 2017 400.00%
Mar 31, 2017 500.00%
Dec 31, 2016 -61.54%
Sep 30, 2016 -50.00%
Jun 30, 2016 -60.00%
Mar 31, 2016 -75.00%
Dec 31, 2015 225.00%
Sep 30, 2015 100.00%
Jun 30, 2015 1,455.86%
Mar 31, 2015 500.00%
Dec 31, 2014 500.00%
Sep 30, 2014 1,032.18%
Jun 30, 2014 63.12%
Mar 31, 2014 50.00%
Dec 31, 2013 0.00%
Sep 30, 2013 93.56%
Jun 30, 2013 0.00%
Mar 31, 2013 -100.00%
Dec 31, 2012 75.00%
Sep 30, 2012 -150.00%
Jun 30, 2012 66.67%
Mar 31, 2012 80.00%